Research, Projects & Studies
The Commission funds several antimicrobial resistance projects through its Health Programme and its research programmes.
For example, the Commission allocated funds (by the European Parliament) for a preparatory action to promote the appropriate use of antimicrobials in human medicine: the ARNA project (Antimicrobial Resistance and causes of non-prudent use of antibiotics in human medicine).
Since 2005, the Executive Agency for Health and Consumers (CHAFEA) manages calls for proposals for projects and organises grants, conferences and relations with the beneficiaries of health programme funding.
The Directorate General for Research and Innovation has also given a significant financial support to a number of projects aiming to tackle the global problem of AMR.
Furthermore, within the scope of the Innovative Medicines Initiative (IMI) - a partnership between the EU (through the Commission) and the European pharmaceutical industry - funds are also being allocated to research on antimicrobial resistance.